Accenture to back Santen Pharmaceutical to build a enterprise platform
Category: #headlines  By Saipriya Iyer  Date: 2019-11-01
  • share
  • Twitter
  • Facebook
  • LinkedIn
Accenture to back Santen Pharmaceutical to build a enterprise platform

Accenture is one of the leading global professional services company which offers a wide range of solutions and services in consulting, strategy, digital technology and operations. With over 492,000 employees serving customers in over 120 nations, the company has made its presence by driving innovations that enrich lives and business.

Recently, Accenture made headlines when it announced that it has been nominated by Santen Pharmaceutical Co., Ltd., a Japan-based ophthalmic pharmaceutical company, to help it create a global intelligent enterprise platform that would accelerate the firm’s digital transformation.

As per reports, the IT company would assist Santen to migrate its major processes and data for finance & accounting, supply chain management and various other operations to SAP S/4HANA®. The latest platform would consolidate data at all its units in over 20 countries and nations.

Moreover, Accenture will use its digitally integrated, insight-driven platform, Accenture myConcerto, to allow Santen to develop a common system template for every facility before commencing implementation. 

Reportedly, Santen will start employing SAP S/4HANA at all its facilities throughout Southeast Asia, with the intention of eventually launching it across all other facilities worldwide. Additionally, Accenture is gathering a global team for this venture that will bring in professionals from the U.S., Japan, China and India.

Speaking on the venture, Noriaki Yamamoto, Head of Information Systems Division, Corporate Officer & CIO, Santen, said that as a dedicated firm devoted to ophthalmology, Santen requires to further improve and standardize the productivity of business processes at every site to maintain its gradual growth and offer benefits to patients across the globe. 

Yamamoto added that this project will mark the foundation for its growth, and the company feels that Accenture’s vast industry expertise as well as broad knowledge of SAP S/4HANA will accelerate the working of this project.
 

Source Credit: https://newsroom.accenture.com/news/accenture-to-help-santen-pharmaceutical-build-a-global-intelligent-enterprise-platform-on-sap-s4hana-to-drive-its-digital-transformation.htm

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Saipriya Iyer

Saipriya Iyer    

Saipriya Iyer currently works as a content developer for GroundAlerts. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had previous experience of 3 years under her belt, she has dabbled with website ...

Read More >>

More News By Saipriya Iyer

Global Wooden Furniture Market by Key Players, Countries, Segments and Application, Forecast to 2027
Global Wooden Furniture Market by Key Players, Countries, Segments and Application, Forecast to 2027
By Saipriya Iyer

Global wooden furniture market is poised to witness a tremendous growth over the projected timeframe of 2020 to 2026 on account of rising number of residential and commercial construction activities across the globe. Alongside, increasing consumer in...

Cladribine Market Growth Manufacturers, Regions, Product Types, Major Application Analysis & Forecast To 2026
Cladribine Market Growth Manufacturers, Regions, Product Types, Major Application Analysis & Forecast To 2026
By Saipriya Iyer

Global Cladribine Market Research Report: Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2026 Executive summ...

Cardiovascular Disease Drugs Market size and Key Trends in terms of volume and value 2021-2026
Cardiovascular Disease Drugs Market size and Key Trends in terms of volume and value 2021-2026
By Saipriya Iyer

Global Cardiovascular Disease Drugs ?Market report 2026 focuses on the major Types and Applications for the key players. Global Cardiovascular Disease Drugs market research report also provides analysis of the market share, segmentation, revenue fore...